Synthetic biology is an emerging interdisciplinary field that integrates knowledge and techniques from biology, genomics, engineering, and informatics.

In the field of bioengineering, protein design has always been a challenging task. With the rapid development of artificial intelligence (AI) technology, especially the breakthroughs in deep learning algorithms, AI-driven protein design is sparking a revolution.

In recent years, China has been making significant strides in the field of biotechnology, positioning itself as a potential global leader in the export of biological products.

In the rapidly evolving landscape of pharmaceuticals, recombinant protein drugs have emerged as a cornerstone of modern healthcare.

In the quest for a sustainable future, the role of high-quality biological products cannot be overstated. These products, derived from living organisms or their byproducts, are revolutionizing industries and contributing significantly to environmental sustainability.

In the ever-evolving world of biopharmaceuticals, Kexing Biopharm stands as a beacon of innovation, dedicated to the R&D, production, and sales of cutting-edge recombinant protein drugs and microecological preparations.

In the realm of biopharmaceutical innovation, Kexing Biopharm stands as a beacon of cutting-edge R&D, production, and sales.

In the heart of China's biopharmaceutical landscape, Kexing Biopharm stands as a pioneer and a leader, dedicated to the industrialization of genetic engineering drugs.